Drug Patents owned by Fresenius Medcl

1. List of Phoslyra drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8592480 FRESENIUS MEDCL Liquid compositions of calcium acetate
Jul, 2027

(4 years from now)

US9089528 FRESENIUS MEDCL Liquid compositions of calcium acetate
Jul, 2027

(4 years from now)

US8591938 FRESENIUS MEDCL Liquid compositions of calcium acetate
Feb, 2030

(7 years from now)

Drugs and Companies using CALCIUM ACETATE ingredient

Market Authorisation Date: 18 April, 2011

Treatment: Use of phoslyra for reduction of serum phosphorous in patients

Dosage: SOLUTION;ORAL

How can I launch a generic of PHOSLYRA before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in